Clinical Application Testing
Assessing authentication, authorization, and data exposure in clinical applications, including whether access controls hold under manipulation.
Custom Software
Hire Healthcare Penetration Testers
Healthcare penetration testers assess clinical systems for exploitable weakness under documented authorization. They test applications, networks, and access controls while working within constraints clinical environments impose, and they report findings with the clinical consequence of each rather than by generic severity alone.
Testing clinical systems carries risks ordinary penetration testing does not. An aggressive scan can disrupt a medical device or degrade a system clinicians depend on, and testing during care hours affects patients. Scope, timing, and technique require negotiation rather than standard methodology. Our hire dedicated developers hub covers remediation roles.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Healthcare Penetration Testers Assess
Work spans application, network, and access control testing with clinical constraints throughout. The work below reflects that, alongside verification practices in our quality assurance approach.
Authorization Bypass Assessment
Testing whether role and relationship-based access can be circumvented, since this determines whether one user can reach another patient’s records.
Network and Segmentation Validation
Testing whether segmentation holds in practice, since designed isolation frequently differs from what network configuration actually enforces.
API and Interface Testing
Assessing clinical APIs and interfaces for exposure, following the security considerations in our healthcare integration services.
Social Engineering Where Authorized
Testing human controls where your organization authorizes it, which frequently reveals more than technical testing in clinical settings.
Findings Reporting With Clinical Context
Reporting each finding with what it exposes clinically, since severity ratings without clinical consequence do not support prioritization.
Clinical Testing Context This Role Requires
Testing clinical environments requires restraint that general penetration testing does not. Systems support active care, devices are fragile, and disruption has patient consequences. The context below spans the healthcare work you assign.
01
Testing Can Disrupt Care
Aggressive techniques can degrade or crash clinical systems and devices. Technique selection is a patient safety decision rather than a methodology preference.
02
Medical Devices Are Fragile
Devices respond unpredictably to scanning. Testing them requires vendor consultation and frequently isolated environments rather than production assessment.
03
Authorization Must Be Explicit and Documented
Testing without documented authorization is indistinguishable from attack. Scope, timing, and technique are agreed in writing before anything begins.
04
Findings Must Be Reported Immediately Where Severe
Discovering active exposure or existing compromise requires immediate notification rather than waiting for a report at engagement end.
05
Real Patient Data Is Not a Demonstration Tool
Proving access does not require extracting records. Demonstration must establish the finding without exfiltrating clinical data.
06
Severity Requires Clinical Translation
A technically severe finding may expose little clinically, and the reverse occurs too. Reporting must convey what is actually at risk.
Technical Skills This Work Requires
The differentiating skills are restraint and clinical translation rather than exploitation breadth. The competencies below reflect that, informed by practices in our HIPAA engineering guidance.
Application Security Testing
Assessing authentication, authorization, injection, and logic flaws in clinical applications with techniques that do not disrupt operation.
Authorization Model Analysis
Testing complex clinical access rules including relationship and consent-based restrictions, which are harder to assess than role-based models.
Network Testing Under Constraint
Validating segmentation without techniques that risk device disruption, which requires technique selection informed by what is connected.
API and Interface Assessment
Testing clinical interfaces for exposure and authorization bypass, including whether endpoints enforce what the interface implies.
Safe Demonstration Technique
Establishing findings without extracting clinical data, since proving access by exfiltrating records creates the exposure being reported.
Clinical Impact Reporting
Translating technical findings into clinical consequence, following documentation practices under our certifications and compliance approach.
How We Evaluate Healthcare Penetration Testers
The distinguishing question is what they declined to test. Testers applying standard methodology to clinical environments risk disruption that harms patients. Our assessment centers on restraint and clinical translation. Our delivery process includes review points where you can reassess fit.
Techniques They Declined
We ask what they chose not to do in a clinical environment. Testers applying standard methodology without adjustment risk disrupting active care.
Device Testing Approach
We ask how they handled medical devices. Testers scanning devices in production without consultation have created risk they may not have recognized.
Immediate Reporting Practice
We ask what they did on finding active exposure. Testers waiting for the final report delayed remediation of something already being exploited.
Demonstration Discipline
We ask how they proved access. Testers extracting patient records to demonstrate a finding created the exposure they were reporting.
Clinical Impact Translation
We ask how findings were prioritized. Severity ratings without clinical context do not help organizations decide what to fix first.
Verified Clinical Testing Experience
We describe which environments each tester assessed and under what authorization. We do not claim security certifications for testers who lack them.
Engagement Options for Testing Work
Engagements require documented authorization and negotiated scope before any testing. Structures below reflect that, and our engagement models accommodate assessment or ongoing arrangements.
Scope and Authorization Definition First
Agreeing what will be tested, when, with what techniques, in writing, since testing without documented authorization is indistinguishable from attack.
Application Assessment Engagement
Testing a defined clinical application for authorization, exposure, and logic weakness with findings reported by clinical consequence.
Segmentation Validation
Testing whether network isolation holds in practice, which frequently reveals gaps between designed and configured segmentation.
Augmenting Your Security Testing
Where you run a testing program, staff augmentation adds clinical environment expertise within your existing methodology and rules of engagement.
Testing Alongside Development
A dedicated healthcare development team can include assessment during development, catching weaknesses before production rather than after.
Fixed-Scope Assessment Delivery
Where scope and authorization are defined, a fixed-scope engagement delivers testing with findings, clinical impact, and remediation guidance.
Tell Us What Cannot Be Disrupted
Share which systems support active care and which devices are connected. Those constrain technique more than the assessment objective does.
Authorization, Safety, and Testing Boundaries
Testing clinical systems risks disruption and requires explicit authorization. We build to HIPAA-aligned practices where HIPAA applies; software cannot be HIPAA certified, and testing does not certify security. Decisions about remediation belong to your organization.
01
Documented Authorization Before Any Testing
Scope, timing, and permitted techniques are agreed in writing, since the same activity without authorization is an attack rather than an assessment.
02
Techniques Selected for Clinical Safety
Methods that risk disrupting systems supporting active care are excluded or moved to isolated environments regardless of what they might reveal.
03
Severe Findings Reported Immediately
Active exposure or evidence of existing compromise is reported at once rather than held for the final report, since delay extends the exposure.
04
No Clinical Data Extracted
Findings are demonstrated without exfiltrating patient records, since proving access by taking data creates the harm being reported.
05
Sensitive System Testing Care
Systems holding behavioral health data require additional restraint. We built CHIPSS, a behavioral health system, where such handling was foundational.
06
Testing We Would Not Perform
We would not test without documented authorization, use techniques risking disruption of active care, or extract clinical records to demonstrate findings.
Cost to Engage Testing Work
Cost tracks scope breadth and constraint complexity rather than system count. Clinical environments require more preparation and more careful technique than corporate ones. We publish no figures on findings volume, because that depends on your environment.
MVP or Single Module
$40,000 to $80,000
Assessment of one clinical application or network segment with authorization definition, testing, findings, and clinical impact reporting.
Full Platform Build
$80,000 to $200,000
Assessment across applications, interfaces, and network segmentation with remediation guidance and retest of addressed findings.
Enterprise Deployment
Starting at $200,000
Multi-facility assessment with device environment testing, segmentation validation across sites, and coordinated reporting.
Discovery Phase Scoping
Discovery is paid and time-boxed. It produces scope definition, authorization documentation, technique constraints, and an itemized fixed-scope estimate.
Cost Drivers to Expect
Scope breadth, application complexity, authorization model intricacy, device environment constraints, testing window limitations, and retest requirements.
Ongoing Support Costs
Environments change and new weaknesses appear. Budget for periodic reassessment and retest after remediation rather than treating testing as one-time.
Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly.
Why Engage Testing Through Taction
Two questions matter. Whether the tester exercises restraint in clinical environments, and whether findings carry clinical translation. Taction Software has built healthcare software since 2013, more than twelve years, with over 200 healthcare projects delivered and ISO 27001 certification. Leadership brings more than twenty years of personal experience in the field, which is separate from company age.
We Build the Systems We Test
We build clinical software, which means we know where weaknesses typically occur and can translate findings into remediation your team can act on.
Clinical Systems Built From the Inside
We built Voyant Health, an EHR platform, and CHIPSS, a behavioral health system, which informs what findings actually expose clinically.
ISO 27001 Certified Information Security
Taction Software holds ISO 27001 certification covering our own information security management practices, which reflects external assessment of how we operate.
We Decline Techniques That Risk Care
Methods that could disrupt systems supporting active treatment are excluded, which limits what we test and prevents harm the assessment would cause.
We Report Severe Findings Immediately
Active exposure reaches you at discovery rather than at report delivery, since holding it for a document extends the exposure unnecessarily.
We Prove Findings Without Taking Data
Access is demonstrated without extracting records, since exfiltrating patient data to prove a point creates the harm we are reporting.
FAQs
Frequently Asked Questions
We define scope, timing, and permitted techniques in writing with your authorization, then present testers with clinical environment experience for approval.
One application or segment runs $40,000 to $80,000, broader assessment $80,000 to $200,000, and multi-facility testing starts at $200,000. Retesting is itemized separately.
Our delivery history includes the Voyant Health EHR platform, the CHIPSS behavioral health system, and the FDA-registered applications Revive Ease and PainKare, within more than 200 healthcare projects delivered since 2013.
With vendor consultation and usually in isolated environments. Scanning devices in production risks disruption that could affect patients, so we decline that approach.
We select techniques to avoid it, which means declining some methods. Where a technique carries disruption risk, we exclude it or move it to a test environment.
Security engineers build and remediate controls. Penetration testers assess whether controls hold, which is an independent function best performed by different people.
Share your systems, which support active treatment, your device estate, your testing windows, your authorization process, and the engagement model you have in mind. We will define scope and technique constraints in writing before testing. We do not certify security.